Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 6 February 1981:
Vol. 211. no. 4482, pp. 584 - 586
DOI: 10.1126/science.7455696

Articles

Science, Vol 211, Issue 4482, 584-586
Copyright © 1981 by American Association for the Advancement of Science


articles

Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E

RE Gregg, LA Zech, EJ Schaefer, and HB Brewer Jr

The apolipoprotein E isolated from plasma of individuals with type III hyperlipoproteinemia (HLP) shows an abnormal pattern when it is examined by isoelectric focusing. Compared to apolipoprotein E from normal subjects, apolipoprotein E isolated from subjects with type III HLP had a decreased fractional catabolic rate in vivo in both type III HLP patients and normal individuals. The delayed catabolism of apolipoprotein E in type III HLP patients may be responsible for the lipid and lipoprotein abnormalities characteristic of these patients.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency.
G. Gerritsen, C. C. van der Hoogt, F. G. Schaap, P. J. Voshol, K. E. Kypreos, N. Maeda, A. K. Groen, L. M. Havekes, P. C. N. Rensen, and K. W. van Dijk (2008)
J. Lipid Res. 49, 1048-1055
   Abstract »    Full Text »    PDF »
Integrated Single-Label Liquid-Phase Assay of APOE Codons 112 and 158 and a Lipoprotein Study in British Women,.
M. R. Abdollahi, P. A.I. Guthrie, G. D. Smith, D. A. Lawlor, S. Ebrahim, and I. N.M. Day (2006)
Clin. Chem. 52, 1420-1423
   Abstract »    Full Text »    PDF »
Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158->Cys), and E3-Leiden.
S.-J. Lee, I. Grosskopf, S. Y. Choi, and A. D. Cooper (2004)
J. Lipid Res. 45, 2199-2210
   Abstract »    Full Text »    PDF »
Apolipoprotein E Polymorphism in Northwestern Greece: Frequency and Effect on Lipid Parameters.
E. Liberopoulos, G. Miltiadous, M. Hatzivassiliou, N. Ayrton, E. Bairaktari, M. Cariolou, and M. Elisaf (2004)
Ann. Clin. Lab. Sci. 34, 347-354
   Abstract »    Full Text »    PDF »
Isoform-Dependent Cholesterol Efflux From Macrophages by Apolipoprotein E Is Modulated by Cell Surface Proteoglycans.
M. Hara, T. Matsushima, H. Satoh, N. Iso-o, H. Noto, M. Togo, S. Kimura, Y. Hashimoto, and K. Tsukamoto (2003)
Arterioscler. Thromb. Vasc. Biol. 23, 269-274
   Abstract »    Full Text »    PDF »
Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia.
J. S. Cohn, M. Tremblay, R. Batal, H. Jacques, L. Veilleux, C. Rodriguez, P. H. R. Barrett, D. Dubreuil, M. Roy, L. Bernier, et al. (2002)
J. Lipid Res. 43, 1464-1471
   Abstract »    Full Text »    PDF »
Strategies to Protect the Brain During Cardiac Surgery.
M. F. Newman, T. O. Stanley, and H. P. Grocott (2000)
Seminars in Cardiothoracic and Vascular Anesthesia 4, 53-64
   Abstract »    PDF »
Age-Dependent Association of Apolipoprotein E Genotypes With Stroke Subtypes in a Japanese Rural Population.
Y. Kokubo, A. H. Chowdhury, C. Date, T. Yokoyama, H. Sobue, and H. Tanaka (2000)
Stroke 31, 1299-1306
   Abstract »    Full Text »    PDF »
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
R. Batal, M. Tremblay, P. H. R. Barrett, H. Jacques, A. Fredenrich, O. Mamer, J. Davignon, and J. S. Cohn (2000)
J. Lipid Res. 41, 706-718
   Abstract »    Full Text »
Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
K. Tsukamoto, C. Maugeais, J. M. Glick, and D. J. Rader (2000)
J. Lipid Res. 41, 253-259
   Abstract »    Full Text »
Rapid Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of ApoE in ApoE-Deficient Mice.
K. Tsukamoto, R. Tangirala, S. H. Chun, E. Pure, and D. J. Rader (1999)
Arterioscler. Thromb. Vasc. Biol. 19, 2162-2170
   Abstract »    Full Text »    PDF »
Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients.
C. Marcoux, M. Tremblay, K. Nakajima, J. Davignon, and J. S. Cohn (1999)
J. Lipid Res. 40, 636-647
   Abstract »    Full Text »
Genetic Predictors of Perioperative Neurologic and Neuropsychological Injury and Recovery.
M. F. Newman, D. T. Laskowitz, A. M. Saunders, A. M. Grigore, and H. P. Grocott (1999)
Seminars in Cardiothoracic and Vascular Anesthesia 3, 34-46
   Abstract »    PDF »
Prevalence of Double Pre-Beta Lipoproteinemia in Hyperlipidemic Patients Is Influenced by Gender, Menopausal Status, and ApoE Phenotype.
J. S. Cohn, L.-M. Giroux, L.-J. Fortin, and J. Davignon (1997)
Arterioscler. Thromb. Vasc. Biol. 17, 2630-2637
   Abstract »    Full Text »
Patients With ApoE3 Deficiency (E2/2, E3/2, and E4/2) Who Manifest With Hyperlipidemia Have Increased Frequency of an Asn 291->Ser Mutation in the Human LPL Gene.
H. Zhang, P. W. A. Reymer, M.-S. Liu, I. J. Forsythe, B. E. Groenemeyer, J. Frohlich, J. D. Brunzell, J. J. P. Kastelein, M. R. Hayden, and Y. Ma (1995)
Arterioscler. Thromb. Vasc. Biol. 15, 1695-1703
   Abstract »    Full Text »
Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans.
J. Hoeg, S. Demosky Jr, R. Gregg, E. Schaefer, and H. Brewer Jr (1985)
Science 227, 759-761
   Abstract »    PDF »
Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment.
H. B. BREWER Jr., L. A. ZECH, R. E. GREGG, D. SCHWARTZ, and E. J. SCHAEFER (1983)
Ann Intern Med 98, 623-640
   Abstract »    PDF »
Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.
G Ghiselli, E. Schaefer, P Gascon, and H. Breser Jr (1981)
Science 214, 1239-1241
   Abstract »    PDF »
Regulation of plasma cholesterol by lipoprotein receptors.
M. Brown, P. Kovanen, and J. Goldstein (1981)
Science 212, 628-635
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)